[18F] -JNJ-70099731

N/A

Report date: 2022/12/26 08:58:05

Base Information

Drug Name[18F] -JNJ-70099731
Drug Alias Name[18F] -JNJ-70099731
ClassificationRadiation-emitting products
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A